Clinical evaluation of the Heart Check system, a new quantitative measurement of fresh capillary BNP

Biomarkers in Medicine

Volumn 9, Issue 12, 2015, Pages 1323-1330

  Monfort, Astrid ^a,b   Silva, Kelly Da ^b   Vodovar, Nicolas ^a,c   Gayat, Etienne ^a,b,c   Cohen Solal, Alain ^a,b,c   Manivet, Philippe ^a,b,c  

^a University of Paris   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

BNP; capillary whole blood; chronic heart failure; correlation; evaluation; immunoassay; patient dyspnea assessment; point of care; reference method; sensitivity; specificity

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIAGNOSTIC KIT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DYSPNEA; FEASIBILITY STUDY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART REHABILITATION; HUMAN; IMMUNOASSAY ANALYZER; INSTRUMENT VALIDATION; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; BLOOD; CAPILLARY; DIAGNOSTIC KIT; IMMUNOASSAY; METABOLISM; MIDDLE AGED; POINT OF CARE SYSTEM; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; STANDARD;

AGED; CAPILLARIES; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; ROC CURVE;

EID: 84948671228     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.15.95     Document Type: Article

References (19)

1. Mcmurray JJ, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33(14), 1787-1847 (2012).
2. Yancy CW, Jessup M, Bozkurt B et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 62(16), e147-e239 (2013).
3. De Vecchis R, Esposito C, Di Biase G et al. B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: A systematic review with meta-analysis. J. Cardiovasc. Med. (Hagerstown) 15(2), 122-134 (2014).
4. Jourdain P, Jondeau G, Funck F et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP multicenter study. J. Am. Coll. Cardiol. 49(16), 1733-1739 (2007).
5. Troughton RW, Frampton CM, Brunner-La Rocca HP et al. Effect of b-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: An individual patient meta-analysis. Eur. Heart J. 35(23), 1559-1567 (2014).
6. Cheng V, Kazanagra R, Garcia A et al. A rapid bedside test for b-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. J. Am. Coll. Cardiol. 37(2), 386-391 (2001).
7. Vogeser M, Jacob K. B-type natriuretic peptide (bnp)-validation of an immediate response assay. Clin. Lab. 47(1-2), 29-33 (2001).
8. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid b-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J. Am. Coll. Cardiol. 39(2), 202-209 (2002).
9. Ro R, Thode HC Jr., Taylor M, Gulla J, Tetrault E, Singer AJ. Comparison of the diagnostic characteristics of two b-type natriuretic peptide point-of-care devices. Emergen. Med. 41(6), 661-667 (2011).
10. Shah K, Terracciano GJ, Jiang K, Maisel AS, Fitzgerald RL. Comparability of results between point-of-care and automated instruments to measure b-type natriuretic peptide. West J. Emerg. Med. 11(1), 44-48 (2010).
11. Maisel A, Barnard D, Jaski B et al. Primary results of the habit trial (heart failure assessment with BNP in the home). J. Am. Coll. Cardiol. 61(16), 1726-1735 (2013).
12. Lang NN, Wong CM, Dalzell JR, Jansz S, Leslie SJ, Gardner RS. The ease of use and reproducibility of the Alere heart check system: A comparison of patient and healthcare professional measurement of bnp. Biomark. Med. 8(6), 791-796 (2014).
13. Heartcheck BNP test strip, package insert, 0017 spec-0363 rev. 1 2010/09, Alere Technologies ltd., Stirling, Scotland.
14. Mongia SK, La'ulu SL, Apple FS, Ler R, Murakami MM, Roberts WL. Performance characteristics of the architect brain natriuretic peptide (BNP) assay: A two site study. Clin. Chim. Acta 391(1-2), 102-105 (2008).
15. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 29(19), 2388-2442 (2008).
16. St John A, Price CP. Economic evidence and point-of-care testing. Clin. Biochem. Rev. 34(2), 61-74 (2013).
17. Kong MC, Lim TG, Ng HJ, Chan YH, Lee LH. Feasibility, cost-effectiveness and patients' acceptance of point-of-care inr testing in a hospital-based anticoagulation clinic. Ann. Hematol. 87(11), 905-910 (2008).
18. Triage® bnp testm, package insert, 2011, Alere Technologies Ltd., Stirling, Scotland.
19. The R Project for Statistical Computing. www. r-project. org/